Agios Pharmaceuticals (NASDAQ:AGIO) Q3 2026 Earnings Call
Agios Pharmaceuticals (NASDAQ:AGIO) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
- Period
- Q3 2026 earnings call
- Date
- Thu, Nov 5, 2026, 8:00 AM ET
On 6ix: 6ix.com/event/agios-pharmaceuticals-inc-agio-q3-2026-earnings-call
Latest news releases
- NASDAQ:AGIO — Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease and AG-236 in Polycythemia Vera at ASH 2026 · Wed, Nov 4, 2026
- NASDAQ:AGIO — Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA · Fri, Oct 30, 2026